Perspective Therapeutics ... (CATX)
AMEX: CATX
· Real-Time Price · USD
3.58
-0.32 (-8.21%)
At close: Aug 15, 2025, 3:59 PM
3.61
0.98%
After-hours: Aug 15, 2025, 05:40 PM EDT
Perspective Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 28.85M | 44.41M | 61.58M | 226.44M | 252M | 142.12M | 9.24M | 17.98M | 28.32M | 36.45M | 20.99M | 18.99M | 55.89M | 58.9M | 60.35M | 61.69M | 63.83M | 64.84M |
Short-Term Investments | 162.73M | 167.3M | 165.34M | 41.4M | 40.87M | 38.53M | n/a | n/a | 22.76M | 35.12M | 22.76M | 35.12M | 22.76M | 35.12M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 322K | n/a | n/a | n/a | 133K | 182K | 182K | 182K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 401K | 366K | 72K | 694K | 854K | 664K | 182K | 2.79M | 2.84M | 2.84M | 2.46M | 2.45M | 2.52M | 843K | 926K | 1.09M | 258K | 491K |
Receivables | 225K | 78K | 1.48M | 217K | 142K | 999K | 1.17M | 1.73M | 1.11M | 1.36M | 7.45M | 1.21M | 1.61M | 2.14M | 1.65M | 1.9M | 2.01M | 2.02M |
Inventory | n/a | n/a | -1.37M | n/a | n/a | n/a | n/a | 1.01M | 1.09M | 1.41M | 1.62M | 1.55M | 1.4M | 1.16M | 1.07M | 1.06M | 980K | 731K |
Other Current Assets | 4.16M | 3.96M | 1.45M | 2.11M | 1.23M | 6.55M | 5.36M | 961K | 1.43M | 1.04M | 727K | 662K | 27K | 662K | 535K | 306K | 481K | 483K |
Total Current Assets | 195.96M | 215.74M | 231.16M | 270.17M | 294.24M | 188.2M | 16.84M | 21.69M | 31.95M | 40.27M | 53.55M | 57.54M | 59.33M | 62.76M | 63.6M | 64.96M | 67.3M | 68.07M |
Property-Plant & Equipment | 64.37M | 63.24M | 59.54M | 46.23M | 16.77M | 15.36M | 6.32M | 8.54M | 7.85M | 7.04M | 2.27M | 2.44M | 2.49M | 2.51M | 2.62M | 2.66M | 2.73M | 2.71M |
Goodwill & Intangibles | 50M | 50M | 50.01M | 74.06M | 74.06M | 74.06M | 74.42M | 77.32M | 77.32M | 77.32M | n/a | 101K | 107K | n/a | 107K | n/a | 130K | n/a |
Total Long-Term Assets | 114.77M | 113.61M | 109.94M | 120.98M | 91.68M | 90.09M | 81.05M | 88.83M | 88.19M | 87.38M | 4.72M | 5M | 5.11M | 3.35M | 3.65M | 3.75M | 3.11M | 3.21M |
Total Assets | 310.73M | 329.35M | 341.1M | 391.15M | 385.92M | 278.29M | 97.89M | 110.52M | 120.14M | 127.64M | 58.28M | 62.54M | 64.44M | 66.11M | 67.25M | 68.71M | 70.42M | 71.28M |
Account Payables | n/a | 8.73M | 10.34M | 21.81M | 6.13M | 6.03M | 6.11M | 3.87M | 4.91M | 3.91M | 1.34M | 2.5M | 966K | 769K | 847K | 768K | 730K | 992K |
Deferred Revenue | 26.6M | n/a | 1.4M | 1.4M | 1.4M | 1.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -294K | -148K | -36K | -100K |
Short-Term Debt | 847K | 53K | 52K | 51K | 54K | 50K | 49K | 341K | 333K | 360K | 276K | 272K | 268K | 264K | 260K | 256K | 252K | 249K |
Other Current Liabilities | -14.46M | 2.91M | 5.48M | n/a | n/a | 5.07M | 5.07M | 3.91M | 3.35M | 2.92M | 879K | 1.23M | 1.03M | 923K | 1.03M | 923K | 855K | 775K |
Total Current Liabilities | 12.99M | 12.68M | 18.23M | 28.14M | 10.61M | 14.5M | 15.66M | 8.12M | 8.59M | 7.19M | 2.5M | 4M | 2.27M | 1.96M | 1.84M | 1.8M | 1.8M | 1.92M |
Long-Term Debt | 1.07M | 1.61M | 1.63M | 1.64M | 1.65M | 1.66M | 1.68M | 2.96M | 2.24M | 1.76M | 116K | 186K | 256K | 324K | 392K | 459K | 524K | 589K |
Other Long-Term Liabilities | 28.48M | 145K | 55K | 33K | 19K | n/a | n/a | 668K | 659K | 666K | 657K | 649K | 640K | 632K | 624K | 693K | 685K | 677K |
Total Long-Term Liabilities | 32.05M | 32.02M | 32.2M | 34.54M | 34.31M | 33.89M | 7.05M | 3.63M | 2.9M | 2.42M | 773K | 835K | 896K | 956K | 1.02M | 1.15M | 1.21M | 1.27M |
Total Liabilities | 45.03M | 44.7M | 50.43M | 62.68M | 44.92M | 48.4M | 22.71M | 11.75M | 11.49M | 9.62M | 3.27M | 4.84M | 3.16M | 2.91M | 2.86M | 2.95M | 3.01M | 3.18M |
Total Debt | 1.92M | 3.82M | 4.06M | 4.27M | 3.88M | 2.88M | 2.55M | 3.31M | 2.58M | 2.12M | 392K | 458K | 524K | 588K | 652K | 715K | 776K | 838K |
Common Stock | 74K | 73K | 70K | 67K | 67K | 587K | 282K | 281K | 280K | 279K | 142K | 142K | 142K | 142K | 142K | 142K | 142K | 141K |
Retained Earnings | -271.38M | -249.9M | -231.72M | -191.55M | -176.43M | -164.72M | -152.44M | -127.77M | -117.41M | -106.3M | -105.57M | -102.67M | -98.6M | -96.52M | -95.17M | -93.57M | -91.33M | -90.26M |
Comprehensive Income | 3K | 19K | -51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.3M |
Shareholders Equity | 265.69M | 284.64M | 290.67M | 328.47M | 341M | 229.89M | 75.18M | 98.77M | 108.65M | 118.03M | 55.01M | 57.7M | 61.28M | 63.2M | 64.39M | 65.76M | 67.41M | 68.1M |
Total Investments | n/a | 167.3M | 165.66M | 41.4M | 40.87M | 38.53M | 133K | 182K | 182K | 182K | 22.76M | 35.12M | 22.76M | 35.12M | n/a | n/a | n/a | n/a |